AILERON THERAPEUTICS INC Contracts & Agreements
67 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (2)
- Human Resources (30)
- Intellectual Property (6)
- Mergers & Acquisitions (1)
- Real Estate (4)
- Uncategorized (6)
- Lung Therapeutics, Inc.2013 Long-Term Incentive Plan, as amended (Filed With SEC on April 15, 2024)
- Aileron Therapeutics, Inc. 2021 Stock Incentive Plan, as amended (Filed With SEC on April 15, 2024)
- Description of Securities of the Registrant (Filed With SEC on April 15, 2024)
- License Agreement, effective as of March 8, 2018, by and between Lung Therapeutics, Inc. and Vivarta Therapeutics, L.L.C (Filed With SEC on January 25, 2024)
- Amended and Restated License Agreement, effective as of September 1, 2018, by and between Lung Therapeutics, Inc. and Medical University of South Carolina Foundation for Research... (Filed With SEC on January 25, 2024)
- Exclusive License Agreement, dated as of November 12, 2020, by and between Lung Therapeutics, Inc. and Taiho Pharmaceutical Co. Ltd (Filed With SEC on January 25, 2024)
- Amended and Restated Patent and Technology License Agreement, effective as of December 19, 2013, by and between Lung Therapeutics, Inc. and the Board of Regents of The University... (Filed With SEC on January 25, 2024)
- Patent License Agreement, effective as of May 21, 2015, by and between Lung Therapeutics, Inc. and the University of Texas at Austin, on behalf of The University of Texas System,... (Filed With SEC on January 25, 2024)
- Agreement and Plan of Merger, dated October 31, 2023, by and among Aileron Therapeutics, Inc., AT Merger Sub I, Inc., AT Merger Sub II, LLC and Lung Therapeutics, Inc (Filed With SEC on October 31, 2023)
- Form of Warrant to Purchase Common Stock to be issued pursuant to the Stock and Warrant Purchase Agreement (Filed With SEC on October 31, 2023)
- Stock and Warrant Purchase Agreement, dated as of October 31, 2023, by and among Aileron Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on October 31, 2023)
- Form of Registration Rights Agreement, by and among Aileron Therapeutics, Inc. and certain purchasers named therein (Filed With SEC on October 31, 2023)
- Executive Employment Agreement, dated as of February 1, 2014, by and between Lung Therapeutics, Inc. and Brian Windsor, Ph.D., as amended (Filed With SEC on October 31, 2023)
- Letter Agreement, dated as of February 11, 2023, by and between Lung Therapeutics, Inc. and Brian Windsor, Ph.D (Filed With SEC on October 31, 2023)
- Letter Agreement, dated as of October 30, 2023, by and between Lung Therapeutics, Inc. and Brian Windsor, Ph.D (Filed With SEC on October 31, 2023)
- Waiver Under Amended and Restated License Agreement, dated as of February 19, 2010, by and among the Registrant, President and Fellows of Harvard College and Dana-Farber Cancer... (Filed With SEC on October 13, 2023)
- Separation and Release of Claims Agreement, dated as of July 8, 2022, between the Registrant and Vojislav Vukovic (Filed With SEC on August 15, 2022)
- Form of Stock Option Agreement under 2021 Stock Incentive Plan (Filed With SEC on March 28, 2022)
- Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan (Filed With SEC on March 28, 2022)
- Sublease Agreement, dated March 26, 2021, by and among the Company, Vittoria Industries North America, Inc. and Waterfront Equity Partners, LLC (Filed With SEC on May 11, 2021)
- Capital on Demand Sales Agreement, dated January 29, 2021, by and among Aileron Therapeutics, Inc. and JonesTrading Institutional Services LLC and William Blair & Company, L.L.C (Filed With SEC on January 29, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on January 7, 2021)
- Registration Rights Agreement, dated as of September 21, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on September 22, 2020)
- Purchase Agreement, dated as of September 21, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on September 22, 2020)
- Underwriting Agreement, dated June 4, 2020, by and between the Company and William Blair & Company, L.L.C (Filed With SEC on June 5, 2020)
- Severance Agreement, dated as of December 12, 2019, between the Registrant and Richard Wanstall (Filed With SEC on March 30, 2020)
- Offer Letter, dated as of June 7, 2018, between the Registrant and Richard Wanstall (Filed With SEC on March 30, 2020)
- Description of Securities of the Registrant (Filed With SEC on March 30, 2020)
- Registration Rights Agreement, dated March 28, 2019, by and among the Company and the persons party thereto (Filed With SEC on April 1, 2019)
- Form of Warrant to Purchase Common Stock to be issued pursuant to the Purchase Agreement (Filed With SEC on April 1, 2019)
- Form of Pre-Funded Warrant to Purchase Common Stock to be issued pursuant to the Purchase Agreement (Filed With SEC on April 1, 2019)
- Securities Purchase Agreement, dated March 28, 2019, by and among the Company and the persons party thereto (the Purchase Agreement) (Filed With SEC on April 1, 2019)
- Offer Letter and Severance Agreement, dated as of November 1, 2018, between the Registrant and Vojislav Vukovic, M.D., Ph.D (Filed With SEC on March 29, 2019)
- Severance Agreement, dated as of October 1, 2018, between the Registrant and Donald V. Dougherty (Filed With SEC on March 29, 2019)
- Offer Letter, dated as of November 15, 2007, between the Registrant and D. Allen Annis, Ph.D (Filed With SEC on March 29, 2019)
- Severance Agreement, dated as of November 5, 2018, between the Registrant and D. Allen Annis, Ph.D (Filed With SEC on March 29, 2019)
- Offer Letter and Severance Agreement, dated as of February 15, 2019, between the Registrant and Kathryn Gregory (Filed With SEC on March 29, 2019)
- Consulting Agreement, dated as of September 30, 2018, between the Registrant and John P. Longenecker, as subsequently amended on December 17, 2018 (Filed With SEC on March 29, 2019)
- Severance Agreement, dated as of September 6, 2018, between the Registrant and Manuel C. Alves Aivado (Filed With SEC on November 7, 2018)
- Consulting Agreement, dated as of September 30, 2018, between the Registrant and John P. Longenecker (Filed With SEC on November 7, 2018)
- Amended and Restated Employment Agreement, dated as of September 6, 2018, between the Registrant and Manuel C. Alves Aivado (Filed With SEC on November 7, 2018)
- Amendment to Lease Agreement, dated as of August 23, 2018, between the Registrant and 480 Arsenal Group LLC (Filed With SEC on November 7, 2018)
- Lease Agreement, effective as of April 4, 2018, between the Registrant and 480 Arsenal Group LLC (Filed With SEC on August 7, 2018)
- Separation and Release of Claims Agreement, dated as of May 15, 2018, between the Registrant and Joseph A. Yanchik III (Filed With SEC on August 7, 2018)
- Employment Agreement, dated as of May 15, 2018, between the Registrant and John P. Longenecker (Filed With SEC on August 7, 2018)
- INDEMNIFICATION AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. 2017 STOCK INCENTIVE PLAN (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. 2017EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 19, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2016 STOCK INCENTIVE PLAN (Filed With SEC on June 2, 2017)
- SEVENTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. 2006 STOCK INCENTIVE PLAN (as most recently amended on October 14, 2014) (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. Incentive Stock Option Agreement Granted Under 2006 Stock Incentive Plan (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. Nonstatutory Stock Option Agreement Granted Under 2006 Stock Incentive Plan (Filed With SEC on June 2, 2017)
- 2016 STOCK INCENTIVE PLAN OF AILERON THERAPEUTICS, INC. TABLE OF CONTENTS (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. NONSTATUTORY STOCK OPTION AGREEMENT GRANTED UNDER 2016 STOCK INCENTIVE PLAN (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENT GRANTED UNDER 2016 STOCK INCENTIVE PLAN (Filed With SEC on June 2, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on June 2, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on June 2, 2017)
- 281 ALBANY STREET CAMBRIDGE,MASSACHUSETTS LEASE SUMMARY SHEET (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2017)
- AILERON THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2017)